Preoperative CEA levels have been observed to have an impact on both overall survival (mOS) and the response to systemic therapy [9, 23], presence of positive tumor deposits in CRLM patients is also associated with a worse outcome [24]. This evidence concerns the gene CEACAM5 and neoplasm.